| # | Side effect | Count |
|---|---|---|
| 0 | OFF LABEL USE | 13196 |
| 1 | DRUG INEFFECTIVE | 9055 |
| 2 | PRODUCT USE IN UNAPPROVED INDICATION | 6165 |
| 3 | DRUG INTERACTION | 5630 |
| 4 | ACUTE KIDNEY INJURY | 5530 |
| 5 | DIARRHOEA | 4599 |
| 6 | TRANSPLANT REJECTION | 4151 |
| 7 | CYTOMEGALOVIRUS INFECTION | 4081 |
| 8 | PYREXIA | 3881 |
| 9 | COVID-19 | 3756 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | MALACOPLAKIA | 397 | 0.8668 |
| 1 | SMOOTH MUSCLE CELL NEOPLASM | 334 | 0.7990 |
| 2 | TRICHODYSPLASIA SPINULOSA | 303 | 0.7953 |
| 3 | PHAEOHYPHOMYCOSIS | 372 | 0.7766 |
| 4 | POLYOMAVIRUS-ASSOCIATED NEPHROPATHY | 1736 | 0.7403 |
| 5 | DELAYED GRAFT FUNCTION | 486 | 0.6835 |
| 6 | POLYOMAVIRUS VIRAEMIA | 716 | 0.6742 |
| 7 | CHRONIC ALLOGRAFT NEPHROPATHY | 465 | 0.5939 |
| 8 | PARVOVIRUS B19 INFECTION | 530 | 0.5922 |
| 9 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER | 2975 | 0.5839 |